These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8794883)

  • 1. A fully active nonglycosylated V2 vasopressin receptor.
    Innamorati G; Sadeghi H; Birnbaumer M
    Mol Pharmacol; 1996 Sep; 50(3):467-73. PubMed ID: 8794883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.
    Oksche A; Schülein R; Rutz C; Liebenhoff U; Dickson J; Müller H; Birnbaumer M; Rosenthal W
    Mol Pharmacol; 1996 Oct; 50(4):820-8. PubMed ID: 8863826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derlin-1 and p97/valosin-containing protein mediate the endoplasmic reticulum-associated degradation of human V2 vasopressin receptors.
    Schwieger I; Lautz K; Krause E; Rosenthal W; Wiesner B; Hermosilla R
    Mol Pharmacol; 2008 Mar; 73(3):697-708. PubMed ID: 18048502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide.
    Schoneberg T; Yun J; Wenkert D; Wess J
    EMBO J; 1996 Mar; 15(6):1283-91. PubMed ID: 8635461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maturation of receptor proteins in eukaryotic expression systems.
    Sadeghi HM; Innamorati G; Birnbaumer M
    J Recept Signal Transduct Res; 1997; 17(1-3):433-45. PubMed ID: 9029506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning, functional expression and tissue distribution of human cDNA for the vascular-type vasopressin receptor.
    Hirasawa A; Shibata K; Kotosai K; Tsujimoto G
    Biochem Biophys Res Commun; 1994 Aug; 203(1):72-9. PubMed ID: 8074728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus.
    Lolait SJ; O'Carroll AM; McBride OW; Konig M; Morel A; Brownstein MJ
    Nature; 1992 May; 357(6376):336-9. PubMed ID: 1534150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/adenylyl cyclase system.
    Birnbaumer M; Gilbert S; Rosenthal W
    Mol Endocrinol; 1994 Jul; 8(7):886-94. PubMed ID: 7984150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function.
    Zhu X; Wess J
    Biochemistry; 1998 Nov; 37(45):15773-84. PubMed ID: 9843382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway.
    Li JG; Chen C; Liu-Chen LY
    Biochemistry; 2007 Sep; 46(38):10960-70. PubMed ID: 17711303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. Molecular basis and clinical implication.
    Schöneberg T; Sandig V; Wess J; Gudermann T; Schultz G
    J Clin Invest; 1997 Sep; 100(6):1547-56. PubMed ID: 9294123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel dual angiotensin II/vasopressin receptor.
    Ruiz-Opazo N
    Nephrologie; 1998; 19(7):417-20. PubMed ID: 9857377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modelling of the vasopressin V2 receptor/antagonist interactions.
    Czaplewski C; Kaźmierkiewicz R; Ciarkowski J
    Acta Biochim Pol; 1998; 45(1):19-26. PubMed ID: 9701492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Linked glycosylation is essential for the functional expression of the recombinant P2X2 receptor.
    Torres GE; Egan TM; Voigt MM
    Biochemistry; 1998 Oct; 37(42):14845-51. PubMed ID: 9778359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of glycosylation in expression and function of the human parathyroid hormone/parathyroid hormone-related protein receptor.
    Bisello A; Greenberg Z; Behar V; Rosenblatt M; Suva LJ; Chorev M
    Biochemistry; 1996 Dec; 35(49):15890-5. PubMed ID: 8961954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin.
    Gimpl G; Postina R; Fahrenholz F; Reinheimer T
    Eur J Pharmacol; 2005 Mar; 510(1-2):9-16. PubMed ID: 15740719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of mechanism of desmopressin binding in vasopressin V2 receptor versus vasopressin V1a and oxytocin receptors: molecular dynamics simulation of the agonist-bound state in the membrane-aqueous system.
    Slusarz MJ; Slusarz R; Ciarkowski J
    Biopolymers; 2006 Apr; 81(5):321-38. PubMed ID: 16333859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional analysis of the canine histamine H2 receptor by site-directed mutagenesis: N-glycosylation is not vital for its action.
    Fukushima Y; Oka Y; Saitoh T; Katagiri H; Asano T; Matsuhashi N; Takata K; van Breda E; Yazaki Y; Sugano K
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):553-8. PubMed ID: 7544576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hydrophobic amino acid residues in the membrane-proximal C tail of the G protein-coupled vasopressin V2 receptor are necessary for transport-competent receptor folding.
    Thielen A; Oueslati M; Hermosilla R; Krause G; Oksche A; Rosenthal W; Schülein R
    FEBS Lett; 2005 Sep; 579(23):5227-35. PubMed ID: 16162341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of the human arginine vasopressin V2 receptor after site-directed mutagenesis of its putative palmitoylation site.
    Schülein R; Liebenhoff U; Müller H; Birnbaumer M; Rosenthal W
    Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):611-6. PubMed ID: 8573100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.